https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-01 / Brain Pathol. 2009 Oct;19(4):694-712
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-01 / Brain Pathol. 2009 Oct;19(4):694-7122009-10-01 00:00:002021-11-15 14:46:05Dendritic cell therapy of high-grade gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-01 / Breast 2009 Oct;18 Suppl 3:S51-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-01 / Breast 2009 Oct;18 Suppl 3:S51-42009-10-01 00:00:002019-02-15 08:50:12Immunizing against breast cancer: a new swing for an old sword
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-01 / Melanoma Res. 2009 Oct;19(5):309-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-01 / Melanoma Res. 2009 Oct;19(5):309-152009-10-01 00:00:002019-02-15 08:49:26Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-01 / Hum. Gene Ther. 2009 Oct;20(10):1106-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-01 / Hum. Gene Ther. 2009 Oct;20(10):1106-182009-10-01 00:00:002019-02-15 08:44:11Dendritic cell-based cancer gene therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-01 / Mol. Cancer Ther. 2009 Oct;8(10):2773-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-01 / Mol. Cancer Ther. 2009 Oct;8(10):2773-92009-10-01 00:00:002019-02-15 08:59:38An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-01 / Brain Pathol. 2009 Oct;19(4):674-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-01 / Brain Pathol. 2009 Oct;19(4):674-932009-10-01 00:00:002019-02-15 08:59:39Immunotherapy of diffuse gliomas: biological background, current status and future developments
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-29 / Clin. Cancer Res. 2009 Oct;15(19):6267-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-29 / Clin. Cancer Res. 2009 Oct;15(19):6267-762009-09-29 00:00:002019-02-15 08:36:11Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-22 / Mol. Ther. 2009 Dec;17(12):2049-57
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-22 / Mol. Ther. 2009 Dec;17(12):2049-572009-09-22 00:00:002019-02-15 08:48:18Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-15 / Exp. Dermatol. 2010 Feb;19(2):108-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-15 / Exp. Dermatol. 2010 Feb;19(2):108-162009-09-15 00:00:002019-02-15 08:48:17Enhanced T-cell activation by immature dendritic cells loaded with HSP70-expressing heat-killed melanoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-13 / Gen Thorac Cardiovasc Surg 2009 Sep;57(9):449-57
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-13 / Gen Thorac Cardiovasc Surg 2009 Sep;57(9):449-572009-09-13 00:00:002019-02-15 08:34:56Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer
